Home > Research Institute > Available Trials > A Phase 2 Study of Alisertib in Patients with Extensive Small Cell Lung Cancer
A Phase 2 Study of Alisertib in Patients with Extensive Small Cell Lung Cancer
A Phase 2 Study of Alisertib in Patients with Extensive Small Cell Lung Cancer
Disease Types: Lung
Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville
A Phase 2 Study of Alisertib in Patients with Extensive Small Cell Lung Cancer
For More information: